Healthcare / Medical DistributionShanghai
$16.35
-0.02 (-0.12%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $690.6M · quality 69.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
44/100
C
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$6.5B
P/E
9.8x
↓EV/EBITDA
5.5x
↓ROE
9.1%
↑Gross Margin
11.0%
↓Debt/Equity
0.56
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+3.2%
FCF CAGR
+40.3%
FCF margin
4.3%
FCF / Net income
1.26x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $20.93B · net income $709.5M · FCF $893.2M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $20.93B | $20.93B | $21.18B | $20.81B | $19.05B |
| Net Income | $709.5M | $709.5M | $854.9M | $849.6M | $701.5M |
| EBITDA | $1.29B | $1.29B | $1.46B | $1.53B | $1.36B |
| EPS | 1.79 | 1.79 | 2.21 | 2.35 | 1.94 |
| Gross Margin | 11.0% | 11.0% | 11.4% | 11.9% | 11.5% |
| Operating Margin | 5.5% | 5.5% | 6.0% | 6.5% | 6.1% |
| Net Margin | 3.4% | 3.4% | 4.0% | 4.1% | 3.7% |
| Balance Sheet | |||||
| Debt/Equity | 0.56 | 0.56 | 0.55 | 0.67 | 0.71 |
| Current Ratio | 1.60 | 1.60 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $893.2M | $893.2M | $690.6M | $421.5M | $323.2M |
| Returns | |||||
| ROE | 9.1% | 9.1% | 11.2% | 12.8% | 11.8% |
| Valuation | |||||
| P/E | 9.85 | 9.85 | 7.80 | 8.26 | 10.41 |
| EV/EBITDA | 5.46 | 5.46 | 4.93 | 5.43 | 5.66 |
| P/B | 0.83 | 0.83 | 0.87 | 1.06 | 1.22 |
| Growth & Yield | |||||
| Revenue Growth | -1.2% | -1.2% | 1.8% | 9.2% | — |
| EPS Growth | -19.0% | -19.0% | -6.0% | 21.1% | — |
| Dividend Yield | 4.8% | 4.8% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-6.8%
EPS terminal req.
$1.45
Spread vs growth
-12.2%
5Y implied EPS CAGR
-0.4%
EPS terminal req.
$1.76
Spread vs growth
-18.6%
10Y implied EPS CAGR
4.7%
EPS terminal req.
$2.83
Spread vs growth
-23.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-0.3%
Start / end P/E
7.8x → 9.1x
EPS bridge
2.21 → 1.79
Residual
-3.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.